Intu Diagnostics
Develops lab-free cervical cancer diagnostics designed to work anywhere, without electricity or access to a laboratory.
Overview
Intu Diagnostics is a German spinout developing a cervical cancer test intended for use outside traditional laboratories. Its platform targets lab-free testing that can move closer to patients, including settings without electricity or clinical infrastructure. The company’s stated differentiator is accessibility: a test that works anywhere without a lab, supporting decentralized screening and earlier detection. Intu Diagnostics has raised about $4 million across two rounds, including a €1.1 million bridge round and more than €3 million in undisclosed funding announced in June 2026.
Funding History
German spinout raises over €3M to tackle cervical cancer with a test that works anywhere without electricity or a lab
Lab-free testing moves closer to home as Germany’s Intu Diagnostics raises €1.1 million
Frequently Asked Questions
- How much has Intu Diagnostics raised in total?
- Intu Diagnostics has raised a total of $4M across 2 funding rounds.
- Who are Intu Diagnostics's investors?
- Intu Diagnostics's investors include BSV Ventures, Saxonian Development Bank, SAB.
- What does Intu Diagnostics do?
- Intu Diagnostics is a German spinout developing a cervical cancer test intended for use outside traditional laboratories. Its platform targets lab-free testing that can move closer to patients, including settings without electricity or clinical infrastructure. The company’s stated differentiator is accessibility: a test that works anywhere without a lab, supporting decentralized screening and earlier detection. Intu Diagnostics has raised about $4 million across two rounds, including a €1.1 million bridge round and more than €3 million in undisclosed funding announced in June 2026.
- Where is Intu Diagnostics headquartered?
- Intu Diagnostics is headquartered in San Francisco, CA.
Related Insights
A comprehensive analysis of Isembard's funding history, investors, competitive position, and growth trajectory in the Deep Tech space.
Compare the leading AI-focused VC firms: Andreessen Horowitz, Sequoia Capital, Thrive Capital, and 7 more. Analysis of 150+ AI deals, investment strategies, sector focus, and portfolio performance.
395 AI funding deals worth $337B tracked in 2026. Complete guide to raising pre-seed, seed, Series A/B/C+ for AI startups. Valuations, metrics VCs demand, top investors (Sequoia, a16z, Lightspeed), and how AI funding differs from traditional tech. Includes real deal sizes, timelines, and founder strategies.